Enhancing the Effect of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Signaling and Arginine Deprivation in Melanoma

Melanoma as a very aggressive type of cancer is still in urgent need of improved treatment. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and arginine deiminase (ADI-PEG20) are two of many suggested drugs for treating melanoma. Both have shown anti-tumor activities without harming...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Chunjing, You, Min, Nguyen, Dao, Wangpaichitr, Medhi, Li, Ying-Ying, Feun, Lynn G., Kuo, Macus T., Savaraj, Niramol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306073/
https://www.ncbi.nlm.nih.gov/pubmed/34299249
http://dx.doi.org/10.3390/ijms22147628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306073/
https://www.ncbi.nlm.nih.gov/pubmed/34299249
http://dx.doi.org/10.3390/ijms22147628

Ejemplares similares